Category Asia/Pacific

لأحكام التجارية القوية للاتحاد الأوروبي حول الملكية الفكرية تعتبر تهديدا على نفاذ البلدان الفقيرة إلى الأدوية

ابروكسل- إن الجهود التي يبذلها الاتحاد الأوروبي لإدراج أحكام حول براءات المستحضرات الصيدلانية في سلسلة من اتفاقات التجارة الحرة التي يتفاوض حولها قد تشكل تهديدا على إمكانية الحصول على الأدوية في البلدان النامية، على حد قول الناشطين في مجال الصحة العامة على الصعيد العالمي.

Des dispositions renforçant la propriété intellectuelle dans certains accords de l’UE menacent l’accès aux médicaments dans les pays pauvres

BRUXELLES - Selon certains activistes de la santé publique mondiale, les efforts de l’Union européenne (UE) pour intégrer des dispositions sur les brevets pharmaceutiques dans un certain nombre d’accords de libre échange en cours de négociation pourraient mettre en péril l’accès aux médicaments dans les pays en développement.

Las estrictas disposiciones comerciales de la UE sobre PI representan una amenaza para el acceso de los países pobres a los medicamentos

BRUSELAS- Los esfuerzos de la Unión Europea para introducir disposiciones firmes en materia de patentes farmacéuticas en una serie de acuerdos de libre comercio que está negociando podrían poner en peligro el acceso a los medicamentos en los países en desarrollo, según han afirmado activistas de la salud pública a nivel mundial.

Strong EU Trade Provisions On IP Seen As Threat To Poor Nations’ Medicines Access

BRUSSELS - Efforts by the European Union to insert strong provisions on pharmaceutical patents in a series of free trade agreements it is negotiating could imperil access to medicines in developing countries, global public health activists have alleged.

As part of trade talks being conducted with India, Colombia, Peru and a regional grouping in south-east Asia, EU officials have proposed that drug-makers should benefit from a robust intellectual property regime. National regulatory authorities in the countries concerned would be prevented for lengthy periods from using data provided by a company that holds a drug patent in order to authorise a generic version of that medicine.

IP From Publicly Funded Research Should Benefit The Public, Experts Say

By Catherine Saez Publicly funded research institutions are major players in the area of life sciences and policies on the management of intellectual property emanating from this research have to be defined, according to speakers at a recent symposium in…

An Alternative Proposal For Enhancing Developing Country Access To Patented Medicines

By Wagdy Sawahel for Intellectual Property Watch An intellectual property model intended to preserve the structure of patent protection while adding balance for developing countries has been proposed to provide incentives for innovators to contribute toward the alleviation of suffering…

IP Roadmap Aims At Facilitating Technology Transfer In The Arab World

By Wagdy Sawahel for Intellectual Property Watch An intellectual property “roadmap” for the Arab world has been proposed for facilitating technology transfer as well as the adaptation of acquired technologies to local needs and contributing to the evolution of new…

Ministers, Stakeholders Meet In Mali To Strategise On Health Research Systems

By Kaitlin Mara Ministers of health, science and technology, and social development met this week with scientific researchers and representatives from foundations, the private sector and civil society to discuss the future of research for health on diseases disproportionately affecting…